Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: To determine glycemic control in adult patients with type 2 diabetes receiving antidiabetic therapy as part of routine healthcare in India. Research design and methods: This was a retrospective analysis of cross-sectional data of patients with type 2 diabetes receiving oral hypoglycemic agents (OHAs) with or without insulin between 2015 and 2017. We assessed proportion of patients with uncontrolled glycemia and performed logistic regression to evaluate its association with various risk factors and microvascular complications. Results: A total of 55 639 eligible records were identified; mean age of patients was 54.31 (±11.11) years. One-third of the study population had microvascular complications, predominantly neuropathy. Nearly 76.6% of patients had uncontrolled glycated hemoglobin (HbA1c) ≥7% (53 mmol/mol); 62% of these patients had HbA1c between 7% and 8% (53–64 mmol/mol). Glycemic control from combination of OHAs with or without insulin varied between 14.2% and 24.8%. In multivariate analysis, factors statistically associated with uncontrolled glycemia were obesity (OR: 1.15), hypertension (stage I OR: 1.65 and stage II OR: 2.73) and diabetes duration >5 years (OR: 1.19) (p<0.001). Similarly, the odds of having any microvascular complication increased with duration of diabetes (past 1–2 years, OR: 1.67; 2–5 years, OR: 2.53; >5 years, OR: 4.01; p<0.0001), hypertension (stage I, OR: 1.18 and stage II, OR: 1.34; p<0.05) and uncontrolled HbA1c (OR: 1.28; p<0.0001). Conclusions: Indian population with type 2 diabetes has a high burden (76.6%) of poor glycemic control. This study highlights the need for early implementation of optimum diabetes pharmacotherapy to maintain recommended glycemic control, thereby reducing burden of microvascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“The landmark UK Prospective Diabetes Study demonstrated that a 1% reduction in glycated hemoglobin (HbA1c) by intensive hypoglycemic therapy is associated with a 37% decrease in risk for microvascular complications.(7) Most guidelines consider HbA1c ≤7% (53 mmol/mol) as the general target of glucose control for optimu…”
BackgroundIDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“InTROduCTIOn The pandemic of diabetes mellitus has affected an estimated 451 million people worldwide in 2017 and is projected to affect 693 million people by 2045.(1) India has emerged as the diabetes capital in the Southeast Asian region having the highest number of people with diabetes (74 million), with an age-adj…”
BackgroundDavies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
Harris, M. I., Klein, R., Welborn, T. A., & Knuiman, M. W. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.815 · Cited by 1,306
Zoungas, S., Arima, H., Gerstein, H. C., Holman, R. R., Woodward, M., Reaven, P., Hayward, R. A., Craven, T., Coleman, R. L., & Chalmers, J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30104-3 · Cited by 529 · cited 1×
“68).(32) Additionally, in people with diabetes, early intensive glucose control therapy not only lowers blood glucose levels but also reduces blood pressure, cholesterol, and its atherogenic subfractions.”
Background
Cited by
Saher, T., Al-Worafi, Y. M., Iqbal, M. N., Wahid, A., Iqbal, Q., Khan, A., Atif, M., & Ahmad, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978345 · Cited by 370
Shamanna, P., Joshi, S., Thajudeen, M., Shah, L., Poon, T., Mohamed, M., & Mohammed, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1485464 · Cited by 56
Feleke, B. E., Feleke, T. E., Kassahun, M. B., Adane, W. G., Fentahun, N., Girma, A., Alebachew, A., Misgan, E., Desyibelew, H. D., Bayih, M. T., et al. (2021) · BioMed Research International · doi:10.1155/2021/6691819 · Cited by 24
Jain, A. B. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.011 · Cited by 8
Metadata
- Authors
- Borgharkar, S. S., & Das, S. S.
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2019-07
- Volume
- 7
- Issue
- 1
- Pages
- e000654
- ISSN
- 2052-4897 (ISSN-L)
- OpenAlex
- W2957442078
- Cited by
- 145
- References
- 7
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-000654
- The paper
- Borgharkar, S. S., & Das, S. S. (2019). Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-000654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.